Genetic variants of CYP2A6 are associated with changes in the activity of the CYP2A6 enzyme, which influences smoking effects and the rate at which some tobacco-specific carcinogens are metabolized, which subsequently determines the incidence of lung cancer. Here, CYP2A6 is linked to lung cancer.